Trial Profile
Association between week 4 HCVRNA and low sustained virologic response (SVR) in patients with detectable hepatitis C virus who are treated with sofosbuvir containing regimen in real world setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Peginterferon; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 Aug 2015 New trial record